Trial Profile
An open-label, parallel, multiple-dose study comparing the pharmacokinetics and gastric acid suppression of rabeprazole extended-release with esomeprazole 40 mg and rabeprazole delayed-release 20 mg in healthy volunteers.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Mar 2011
Price :
$35
*
At a glance
- Drugs Rabeprazole (Primary) ; Esomeprazole
- Indications Gastro-oesophageal reflux; Peptic ulcer
- Focus Pharmacodynamics; Pharmacokinetics
- 29 Mar 2011 New trial record